Home
Scholarly Works
Clinical and Genomic Risk in Adjuvant Therapy for...
Journal article
Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply.
Authors
Sparano JA
Journal
N Engl J Med, Vol. 381, No. 13, pp. 1290–1291
Publication Date
September 26, 2019
DOI
10.1056/NEJMc1909693
Associated Experts
Holger Schunemann
Professor Emeritus, Faculty of Health Sciences
Visit profile
Labels
Medical Subject Headings (MeSH)
Breast Neoplasms
Chemotherapy, Adjuvant
Combined Modality Therapy
Genomics
Humans
Fields of Research (FoR)
32 Biomedical and clinical sciences
42 Health sciences
View published work (Non-McMaster Users)
View published work (McMaster Users)
Scholarly citations from Dimensions
Contact the Experts team
Get technical help
or
Provide website feedback